Singapore's Health Sciences Authority (HSA) has expanded regulatory reliance agreements across Africa, Malaysia and Saudi Arabia, aiming to cut duplicated reviews and speed up access to health products. HSA signed a Memorandum of Understanding (MOU) with the Saudi Food and Drug Authority, covering pre-market and post-market cooperation, technical information sharing, and regulatory pathways for conventional and novel products, including biotechnology and artificial intelligence. Top of Form   Bottom of Form The authority also signed a separate MOU with the African Medicines Agency, establishing a framework for exchanging regulatory information, collaborating on regulatory science, capacity building, and exploring the use of HSA's approvals as references.   https://sbr.com.sg/healthcare/news/singapore-expands-regulatory-reliance-pacts-africa-malaysia-and-saudi-arabia (ICE SINGAPORE)

Fonte notizia: Singapore Business Review, 19 September 2026